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Background: The recent notifications of autochthonous cases of dengue and chikungunya in Europe prove that
the region is vulnerable to these diseases in areas where known mosquito vectors (Aedes albopictus and Aedes aegypti)
are present. Strengthening surveillance of these species as well as other invasive container-breeding aedine mosquito
species such as Aedes atropalpus, Aedes japonicus, Aedes koreicus and Aedes triseriatus is therefore required. In order to
support and harmonize surveillance activities in Europe, the European Centre for Disease Prevention and Control
(ECDC) launched the production of ‘Guidelines for the surveillance of invasive mosquitoes in Europe’. This article
describes these guidelines in the context of the key issues surrounding invasive mosquitoes surveillance in Europe.
Methods: Based on an open call for tender, ECDC granted a pan-European expert team to write the guidelines draft. It
content is founded on published and grey literature, contractor’s expert knowledge, as well as appropriate field
missions. Entomologists, public health experts and end users from 17 EU/EEA and neighbouring countries contributed
to a reviewing and validation process. The final version of the guidelines was edited by ECDC (Additional file 1).
Results: The guidelines describe all procedures to be applied for the surveillance of invasive mosquito species. The first
part addresses strategic issues and options to be taken by the stakeholders for the decision-making process, according
to the aim and scope of surveillance, its organisation and management. As the strategy to be developed needs to be
adapted to the local situation, three likely scenarios are proposed. The second part addresses all operational issues and
suggests options for the activities to be implemented, i.e. key procedures for field surveillance of invasive mosquito
species, methods of identification of these mosquitoes, key and optional procedures for field collection of population
parameters, pathogen screening, and environmental parameters. In addition, methods for data management and
analysis are recommended, as well as strategies for data dissemination and mapping. Finally, the third part provides
information and support for cost estimates of the planned programmes and for the evaluation of the applied
surveillance process.
Conclusion: The ‘Guidelines for the surveillance of invasive mosquitoes in Europe’ aim at supporting the
implementation of tailored surveillance of invasive mosquito species of public health importance. They are intended to
provide support to professionals involved in mosquito surveillance or control, decision/policy makers, stakeholders in
public health and non-experts in mosquito surveillance. Surveillance also aims to support control of mosquito-borne
diseases, including integrated vector control, and the guidelines are therefore part of a tool set for managing
mosquito-borne disease risk in Europe.
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Vector-borne diseases are a specific group of infections
that present a (re-)emerging threat to Europe and therefore
require particular attention [1]. The recent notifications of
autochthonous transmission of dengue and chikungunya
fevers in Europe [2-5], and the outbreak of dengue in
Madeira [6], demonstrate the region’s vulnerability to these
diseases in areas where an effective vector, Aedes albopictus
(Skuse) (Figure 1) or Aedes aegypti Linnaeus, is present.
Strengthening the surveillance of these two species as well
as the other exotic and invasive mosquito species (Table 1),
Aedes atropalpus (Coquillett), Aedes japonicus japonicus
(Theobald), Aedes koreicus (Edwards) and Aedes triseriatus
(Say) in areas at risk of importation or spread of mosquitoes
and risk of virus transmission is therefore required [1]. This
is particularly important in the context of environmental
changes in, for example, land cover or weather patterns
that might lead to an increase of vector populations, vector-
host contact and virus amplification [7-9].
Early detection of invasive mosquito species (IMS) en-
ables appropriate and timely response measures and subse-
quent prevention of mosquito-borne disease (MBD) [10].
In addition, however, in areas where IMS have become
established, timely surveillance of their abundance and
spread is needed to assess the risk of pathogen transmission
to humans [1]. In order to encourage the Member States
to collect appropriate data on IMS in the field and fur-
ther harmonise surveillance procedures within Europe,
the European Centre for Disease Prevention and Control
(ECDC) launched the production of ‘Guidelines for the
surveillance of invasive mosquitoes in Europe’ as part of a
toolset for assessing and controlling a number of risks
posed by IMS and MBDs (Figure 2). This document de-
scribes the guidelines in the context of the key issues sur-
rounding IMS surveillance in Europe.Figure 1 Aedes albopictus, female. Source: F.Schaffner/ECDC.Methods
The mosquito species considered here are all exotic spe-
cies that have been introduced into Europe in recent de-
cades and have proven or are suspected to be invasive.
The proposed surveillance methods are applicable in
the whole of geographical Europe (all European Union/
European Economic Area and neighbouring countries),
including European Union Outermost Regions, but they
are not suitable for the Overseas Countries and Territories,
which have different vector species, diseases, environment,
and climate to the European continent.
‘Surveillance’ (as opposed to ‘monitoring’), is defined here
as a set of procedures developed in response to a recognised
risk and carried out to support subsequent actions. Sur-
veillance of mosquito vectors in Europe can therefore
contribute to a global plan for risk assessment and man-
agement of MBDs (Figures 2, Figure 3).
Development of these guidelines
In order to produce a draft version of these guidelines,
ECDC launched an open call for tenders on 6 April 2011
(OJ/06/04/2011-PROC/2011/023). After a thorough evalu-
ation of all applications, a contract was signed with the
authors, representing a pan-European spectrum of com-
plementary experience and knowledge in mosquito sur-
veillance as applied to IMS.
The guidelines are based on a review of published and
grey literature as well as on field experience of the con-
tract team and external experts from two major European
networks: VBORNET (the European network of medical
entomologists and public health experts, www.vbornet.
eu); and EMCA-AIM-WG (the Aedes albopictus and other
invasive mosquitoes Working Group of the European
Mosquito Control Association, http://www.emca-online.
eu). Moreover, in order to obtain up-to-date information
about mosquito surveillance activities in Europe, two
missions were performed in Spain and Portugal: Spain
has over five years experience of IMS surveillance, while
Portugal has only recently implemented mosquito moni-
toring with little focus on IMS. An additional mission was
carried out in the north-eastern United States (interviewing
research units and mosquito control abatements from
Connecticut, Michigan, and New Jersey) where some vec-
tors, pathogens, and consequently surveillance strategies
are different from those implemented in Europe.
A draft version of the guideline document was reviewed
during an ad hoc meeting at ECDC in Stockholm. Ento-
mologists, public health experts and end users from 17
EU/EEA and neighbouring countries (Albania, Austria,
Belgium, Bulgaria, Croatia, Denmark, France, Germany,
Greece, Italy, Portugal, Romania, Serbia, Spain, Switzerland,
the Netherlands, and the United Kingdom) took part in
the meeting to review, improve and agree on the guide-
lines [11]. As an outcome of this process, a final version
Table 1 Mosquito species names
Traditional name (1906–2000) Reinert et al. 2004 Reinert et al. 2006
Aedes (Stegomyia) aegypti Stegomyia aegypti St. (Ste.) aegypti*
Ae. (Ste.) albopictus St. albopicta
Ae. (Ochlerotatus) atropalpus Ochlerotatus (Och.) atropalpus Georgecraigius (Gec.) atropalpus
Ae. (Finlaya) japonicus Oc. (Fin.) japonicus Hulecoeteomyia japonica
Ae. (Fin.) koreicus Oc. (Fin.) koreicus Hl. koreica
Ae. (Protomacleaya) triseriatus Oc. (Pro.) triseriatus
Major generic changes within the tribe Aedini were recently published [12-14], leading to scientific debate and two or more names being simultaneously used for
a single taxon. In this article we use the traditional names [15,16], with alternate names shown in the table. * Subgenus Stegomyia re-defined in [17].
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The guidelines provide accurate information and tech-
nical support for focused surveillance activities and data
collection in the field. They also provide cost estimatesFigure 2 Procedures and main issues of invasive mosquito species an
rectangles show sources of information and alerts on risks for IMS and MBD
European network of medical entomologists and public health experts (up
central part (central yellow rectangle). The left part is already addressed wit
is dealt with by the EMCA/WHO initiative on guidelines (dark blue rectangle).
and control (dark blue) of IMS. Red rounded rectangles show procedures that
control. WHO Guidelines (www.who.int/ihr/en): In the context of the applicatio
strengthen national capacities by developing and updating guidelines and to
entry (PoE) vector identification platform is under development, as well as a ‘H
handbook focuses on actions that can be performed at PoE and on conveyan
species (including mosquitoes) relevant to major MBDs. EMCA/WHO Guideline
to develop ‘Guidelines for the control of invasive mosquitoes and associated
pan-European consultations. The first deliverable will be a strategy documentand suggest adaptations according to the local context
and the evolution of the epidemiological situation. They
are intended to describe all procedures to be applied to
the surveillance of IMS.
The first part addresses strategic issues and steps to be
taken by the stakeholders for the decision-making process.
According to the aim and scope of surveillance, advice is
provided to define the organisation and management ofd mosquito-borne disease surveillance in Europe. Green rounded
that justify surveillance; part of it is performed within VBORNET, the
per light green rectangle). These guidelines focus and develop the
hin the WHO guidelines (light blue rectangle), whereas the lower part
Blue rounded rectangles show procedures for surveillance (light blue)
are addressed within MBDs risk plans alongside IMS surveillance and
n of the International Health Regulations (IHR 2005), WHO aims to
ols on vector surveillance and control. Thus, a web-based global point of
andbook on vector surveillance and control at points of entry’. This
ces, containers, cargo, postal parcels and baggage. It considers all vector
s: EMCA and WHO European Region have recently launched an initiative
vector-borne diseases on the European continent’, based on
with special emphasis on control issues.
Figure 3 Decision diagram for the implementation of surveillance of invasive mosquito species, in relation to mosquito-borne disease
risk assessment and management. The large blue, orange and red rectangles show activities and decisions related to IMS surveillance, that are
covered by the three scenarios used for defining the surveillance strategies described in the guidelines. Grey rectangles show activities and
decisions to be implemented alongside IMS surveillance, within MBD risk plans, including surveillance of MBDs and control of IMS and MBDs.
Depending on the MBD, indigenous mosquitoes may also be targeted.
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developed. Three likely scenarios are proposed:
 Scenario 1 – No established IMS: There is a risk of
introduction and establishment of IMS but this has
not yet been reported. Surveillance activities are
designed to detect possible introduction and
establishment of IMS at specific points of entry.
 Scenario 2 – Locally established IMS: An IMS
population is locally established in a small area, but with
no evidence of spreading. Surveillance aims to quantify
establishment and detect possible spread of IMS.
 Scenario 3 – Widely established IMS: At least one
IMS population has colonised a large area by
spreading locally. Surveillance aims to assess IMS
population abundance and dynamics.
The risk estimate here is based on presence and abun-
dance of IMS, not on the likelihood of transmission of
MBDs. If the country already faces an outbreak of a MBD,
then surveillance activities may need to be extended/
strengthened, according to complementary guidance for the
surveillance of MBDs and control of vectors and MBDs.
The second part addresses all operational issues and
steps for the activities to be implemented, i.e. key proce-
dures for field surveillance of IMS, methods of identifi-
cation of IMS, key and optional procedures for field
collection of population parameters, pathogen screening,
and evaluation of environmental parameters. This part
also recommends methods for data management and ana-
lysis, as well as strategies for data dissemination and map-
ping. Practical information is given in annexes, tailored
to different audiences, e.g. general information on mos-
quito biology for non-entomologists, original mosquito
identification keys for entomologists, practical tips for
implementing trapping activities for field technicians.
Finally, the third part provides cost estimates for the
planned programmes and sets out the procedures needed
to evaluate the surveillance process. It aims at supporting
planning and cost estimation prior to surveillance imple-
mentation, and at promoting surveillance evaluation and
improvement/readjustment of the procedures.
The guidelines contribute to the harmonisation of sur-
veillance methods and information records at the European
level so that data and experience from different countries/
areas can be compared over time. They are intended to
provide support to professionals involved in implementing
IMS surveillance or control; to decision- and policy-makers
and stakeholders in public health; and also to non-experts
in mosquito surveillance and control.
Why survey mosquitoes in Europe?
Mosquitoes may be of public health relevance either when
they transmit disease to humans, or when they occur insufficient numbers to cause a nuisance. Both indigenous
and invasive mosquito species comprise efficient vectors
of pathogens (e.g. the Asian tiger mosquito, Ae. albopictus,
is competent to transmit at least 22 arboviruses, and the
common house mosquito Culex pipiens pipiens at least
6 arboviruses) as demonstrated by the recent outbreaks
of chikungunya, dengue, and West Nile fevers in the
Mediterranean basin [6,18,19]. In addition to viruses,
mosquitoes may transmit malaria parasites (vector species
belonging exclusively to the genus Anopheles) and dirofilaria
worms in Europe. Indeed, the rapid spread of Ae. albopictus
throughout Italy is likely to have broadened the range of
Dirofilaria immitis and D. repens to include southern
regions not previously infected despite the presence of
Culex pipiens pipiens, which is considered the main in-
digenous vector of both Dirofilaria spp. in Europe [20].
The sympatric occurrence of both vectors, with both
diurnal and nocturnal biting activities, may further en-
hance the risk of transmission to dogs and humans in
many parts of Europe [20]. In recent decades, human
contact with mosquitoes has become more frequent as
suburbs that sprawl into previously undisturbed natural
areas provide a greater number and variety of mosquito
breeding places than do inner-city areas [21]. In addition,
urbanised areas are facing invasion by container-breeding
mosquitoes such as Ae. albopictus which has an aggressive
nuisance behaviour during the day when females are seek-
ing blood meals from humans and domestic animals.
Why focus on invasive mosquitoes?
IMS are defined by their ability to colonise new territories
and to cause or to be likely to cause harm to the economy,
environment, or human health [22]. Human activities are
the primary means of IMS introduction. A considerable
increase in the spread of IMS has been observed within
Europe since the late 1990s, since then Ae. albopictus has
continuously expanded its distribution (Figure 4) and
several other container-breeding Aedes species have been
reported from new countries every year (Figure 5; details
about successive introductions and spread in Europe are
given in [18]). To date, Ae. albopictus has colonised most
Mediterranean countries, and the Asian bush mosquito
Ae. japonicus is spreading widely in Central Europe. Two
other species, Ae. atropalpus and Ae. koreicus, have been
introduced on several occasions, leading to the establish-
ment of populations at few foci. Aedes triseriatus was
intercepted at a point of entry, and its establishment was
prevented by the implementation of immediate control
measures. Finally, the yellow fever mosquito Ae. aegypti,
which had been introduced into Europe during the 17th-
19th centuries existed in coastal areas of southern Europe
until its disappearance during the 20th century, probably
linked to malaria vector control activities and/or urban-
isation and improvement of hygiene, especially in water-
Figure 4 Spread of the Asian tiger mosquito Ae. albopictus within Europe, 1995–2012. Red mapping units (territorial units for statistics NUTS 3) =
presence; grey units = absence or no available information. The figure has been adjusted and updated compared to the figure given in the guidelines.
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having recently become established on Madeira as well as
around the Black Sea coast (Russia, Abkhazia, Georgia).
These invasive mosquito species are well adapted to an-
thropogenic settings where they exploit the abundant
sources of feeding, resting places and larval breeding
sites (mainly man-made water containers) [18]. They may
also reduce biodiversity as they outcompete native mos-
quito species, but the main hazard they pose is the threat
to both human and animal health.Economic and social issues
A considerable amount of money is invested in reducing
the nuisance caused by mosquitoes in Europe, mainly in
tourist regions around the Mediterranean Sea, but also
in flood plains (e.g. Danube, Po, Rhine, or Rhone valleys)
and irrigated agricultural areas (e.g. northern Italy, northern
Greece) [23]. Mosquito control is most often managed by
public agencies implementing medium-term programmes.
The arrival of IMS in cities and peri-urban areas can
affect public perception of the effectiveness of control
programmes already in place. Also control methods must
be adapted to the mosquito species, as controlling mos-
quitoes in containers around human settlements is clearly
different to controlling cohorts of flood plain/marshland
mosquitoes, in terms of available techniques, equipment,
and biocides. In addition, higher suppression efficiency
will be expected for vector control during an outbreakcompared to control of biting nuisance in a MBD-free
context. Indeed, different types of organisations may be
involved for different mosquito types. Local government
and environmental agencies usually deal with nuisance
species, whereas state and public health units are involved
in the control of species that transmit pathogens.
Epidemics of MBDs may also have considerable eco-
nomic impact. A burden of disease analysis performed
on the chikungunya epidemic on La Réunion island in the
Indian Ocean (2005–2006, 204,000 cases) estimated the
total cost of medical expenses at 43.9 million euros, of
which 60% was attributable to direct medical costs and
40% to the disease related loss of productivity [24]. This
represents 56.10 euros per island inhabitant over two
years. Besides medical costs, similarly high expenditures
were involved in combating the disease (including vector
control measures). These costs can be compared to cost
of activities currently supported by the Emilia-Romagna
region of Italy, where 5–6 million euros are spent yearly
on a prevention plan for dengue and chikungunya (includ-
ing the direct costs associated with surveillance, control
and information management) [25]. This represents ap-
proximately 1.4 euros per person in the area at risk.
Current impact of MBDs and threat for the future
Although MBDs (Table 2) currently represent a lower
disease burden in temperate than in tropical regions
where they have a substantial impact on the countries’
socio-economic development, there have always been both
Figure 5 Known distribution of targeted invasive mosquito species by March 2013 (with details on countries and first reports in legend).
Background map: distribution of Ae. albopictus (red: established; yellow: introduced, without confirmed establishment): First reports: Albania 1979,
Italy 1990, spreading into 11 countries of the Mediterranean; localized in Bulgaria 2011; sporadic records without confirmed establishment in Belgium
2000 (not shown), The Netherlands 2005–2012, Germany 2007/2011/2012, Serbia 2009/2011/2012, Turkey and Russia 2011, Austria, Czech Republic and
Slovakia 2012. Mapping units used are territorial units for statistics NUTS 3. ‘Absent’ (green colour) means that surveillance of mosquitoes has been
implemented during the last 5 years without reports of introduction or establishment. Other colours: see legend on the map. Ae. aegypti (orange
circles): Russia 2001, Portugal-Madeira 2004, Abkhazia and Georgia 2007, The Netherlands 2010 [eliminated: not shown]; Ae. japonicus, (blue circles):
France 2000 [eliminated: not shown]), Belgium 2002 [localized], Switzerland and Germany 2008, Austria and Slovenia 2011; Ae. koreicus (white dots):
Belgium 2008 [localized], Italy 2011. Not shown: Ae. atropalpus: Italy 1996 and France 2003 [eliminated], The Netherlands 2009-2011
[eliminated]; Ae. triseriatus France 2004 [intercepted].
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However, mosquitoes introduced into the area may increase
risk to human health by (i) concurrently harbouring novel
pathogens, (ii) transmitting native pathogens, or (iii) trans-
mitting novel pathogens that were independently intro-
duced [26].
In certain areas, IMS may remain undetected for a while,
as for Ae. japonicus in Switzerland, where a first field investi-
gation triggered by a citizen complaint revealed a colonised
area of approximately 1,400 km2, suggesting that the species
had been unnoticed for several years [27]. Aedes albopictus
was present in Albania and Italy for 30 and 17 years,respectively, before the first outbreak of MBD attributed
to this mosquito was reported in Italy. In France, however,
autochthonous cases of chikungunya and dengue were
detected only four years after the species was established.
This suggests that the global context is becoming more
favourable to pathogen introduction (e.g. frequency and
intensity of epidemics in dengue-endemic areas) and that
the local conditions that make the transmission of diseases
carried by IMS possible are now frequently found in Europe.
This is correlated with the vectorial capacity of the
established mosquito populations and the frequency of
vector-host contact [28]. Changes in eco-systems, land
Table 2 Important mosquito-borne pathogens that cause disease in humans
Arboviruses Transmission in Europe Important vectors to human
Chikungunya Italy 2007; France 2010 Ae. aegypti, Ae. albopictus
Dengue 1–4 Until early 20th century in southern Europe;
Croatia and France 2010, Portugal (Madeira) 2012
Ae. aegypti, Ae. albopictus
Eastern equine encephalitis, La Crosse encephalitis,
Rift Valley fever
– Aedes spp., Culex spp.
Japanese encephalitis, Murray Valley encephalitis,




Sindbis Endemic in northern Europe Ae. cinereus, Cx. pipiens
West Nile Endemic in southern Europe Cx. modestus, Cx. pipiens, Cx. perexiguus
Yellow fever Until 19th century, mainly in ports and occasionally
inland in southern Europe
Ae. aegypti, Ae. africanus, Haemagogus spp.
Plasmodium protozoa
Malaria Endemic until mid-20th century; since then
sporadic cases; epidemic in Greece 2011, 2012
Anopheles spp.
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transmission [8,29]. Some of the factors affect several
steps of the transmission cycle: for example, weather
conditions may have a direct influence not only on the
pathogen itself (i.e. higher temperatures allow a faster
replication / dissemination of the pathogen in the mos-
quito) but also affect the vector’s reproduction, activity
and survival [7,9,30]. These relationships can be used to
extrapolate the future possible distribution of a mosquito
species based on its ecological requirements and projected
scenarios of climate change [31-34]. However, so far,
human-induced environmental changes combined with
globalisation and absence of or inefficient public health
measures have been shown to be the primary driving
forces for the emergence and global spread of dengue in
the past 40 years [35].
Conclusions
Mosquito-borne diseases are (re-)emerging threats to
Europe. The collection of information and data on insect
vectors are crucial to understand the levels of risk that
countries face, and to define the actions that need to be
taken. The ‘Guidelines for the surveillance of invasive
mosquitoes in Europe’ aim to support the implemen-
tation of tailored surveillance of IMS of public health
importance. They provide accurate information and tech-
nical support for focused field data collection, proposing
adaptations dictated by the local context and the epi-
demiological situation, and taking into account estimated
costs. They may also contribute to harmonising surveil-
lance methods and information records at the European
level so that data from different countries/areas can be
compared over time and between different areas. They are
also intended to provide support to non-experts inmosquito surveillance, stakeholders in public health, deci-
sion/policy makers, and professionals involved in
implementing IMS surveillance or control.
Currently, the targeted mosquito species are all exotic
invasive Aedes species that have been reported as intro-
duced into Europe to date, including Ae. aegypti, Ae.
albopictus, Ae. atropalpus, Ae. japonicus, Ae. koreicus,
and Ae. triseriatus. They share the common traits of be-
ing container-breeding species, invasive, anthropophilic,
and showing significant vectorial capacity. Of the range
of pathogens that IMS can transmit, dengue and chi-
kungunya are considered as the main threats to human
health, and have been locally transmitted by Ae. aegypti
and Ae. albopictus in Europe and outermost regions.
Threats to animal health and to the environment (par-
ticularly to biodiversity) can also be addressed by
adapting the surveillance methods described in these
guidelines. The proposed methods are applicable in
the whole of geographical Europe, including European
Union Outermost Regions, but not Overseas Countries
and Territories.
Surveillance of IMS aims to support MBDs control,
including integrated vector control. Assessing and man-
aging the risk of introduced MBDs that have become
established in Europe is now a necessity and should also
become a priority, in particular in countries where Ae.
albopictus and/or other IMS are established. The guide-
lines are therefore part of a tool set for managing MBD
risk in Europe. A first evaluation of these guidelines has
been performed in Belgium within a pilot study
implemented in 2012 and results will be published else-
where. Further updates are scheduled for three-year inter-
vals, or whenever a major change in vector fauna or MBD
risk occurs.
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